HomeCARA • NASDAQ
add
Cara Therapeutics Inc
Previous close
$0.34
Day range
$0.33 - $0.35
Year range
$0.24 - $3.03
Market cap
19.28M USD
Avg Volume
442.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 991.00K | -85.71% |
Operating expense | 6.41M | -18.15% |
Net income | -20.02M | 36.41% |
Net profit margin | -2.02K | -344.84% |
Earnings per share | -0.35 | 40.38% |
EBITDA | -16.14M | 50.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 56.62M | -40.21% |
Total assets | 72.50M | -46.06% |
Total liabilities | 60.90M | 139.22% |
Total equity | 11.60M | — |
Shares outstanding | 54.85M | — |
Price to book | 1.64 | — |
Return on assets | -49.86% | — |
Return on capital | -60.51% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -20.02M | 36.41% |
Cash from operations | -12.44M | 39.17% |
Cash from investing | 15.29M | -53.39% |
Cash from financing | -610.00K | — |
Net change in cash | 2.24M | -81.85% |
Free cash flow | -6.65M | 27.13% |
About
Founded
2004
Headquarters
Website
Employees
55